ANDRX TO FILE SEVEN TO 10 ANDAs FOR CONTROLLED RELEASE GENERICS
Executive Summary
ANDRX TO FILE SEVEN TO 10 ANDAs FOR CONTROLLED RELEASE GENERICS "during the second half of 1994 and the first quarter of 1995," the Ft. Lauderdale-based company said in a March 23 prospectus for an initial public offering. Andrx has 15 generics under development, eight of which are expected to be licensed in the U.S. to other firms.